Harry M. Kraemer - May 10, 2021 Form 4 Insider Report for Leidos Holdings, Inc. (LDOS)

Role: Director
Signature: /s/ Ramune M. Kligys, Attorney-in-Fact
Stock symbol: LDOS
Transactions as of: May 10, 2021
Transactions value $: -$14
Form type: 4
Date filed: 5/12/2021, 05:42 PM
Previous filing: May 11, 2021
Next filing: May 20, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LDOS	Common Stock	Options Exercise	$337K	+11.7K	+15.41%	$28.84	87.5K	May 10, 2021	Direct
transaction	LDOS	Common Stock	Tax liability	-$337K	-3.24K	-3.7%	$104.03	84.3K	May 10, 2021	Direct	F1
holding	LDOS	Common Stock						116K	May 10, 2021	By Key Executive Stock Deferral Plan

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LDOS	Stock Option (Right to Buy)	Options Exercise	$0	-11.7K	-100%	$0.00^*	0	May 10, 2021	Common Stock	11.7K	$28.84	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.
F2	This stock option was previously reported as a stock option grant for 8,636 shares of common stock at an exercise price of $39.03 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. This stock option was incorrectly reported previously as allocated to indirect holdings through the issuer's Key Executive Stock Deferral Plan.

Content

Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.

This stock option was previously reported as a stock option grant for 8,636 shares of common stock at an exercise price of $39.03 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. This stock option was incorrectly reported previously as allocated to indirect holdings through the issuer's Key Executive Stock Deferral Plan.